Royal Bank of Canada’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $332K | Buy |
18,332
+8,996
| +96% | +$163K | ﹤0.01% | 4444 |
|
|
2025
Q1 | $191K | Sell |
9,336
-11,022
| -54% | -$225K | ﹤0.01% | 4391 |
|
|
2024
Q4 | $524K | Buy |
20,358
+11,401
| +127% | +$293K | ﹤0.01% | 3627 |
|
|
2024
Q3 | $149K | Buy |
8,957
+151
| +2% | +$2.51K | ﹤0.01% | 4610 |
|
|
2024
Q2 | $169K | Buy |
8,806
+5,356
| +155% | +$103K | ﹤0.01% | 4516 |
|
|
2024
Q1 | $82K | Sell |
3,450
-7,425
| -68% | -$176K | ﹤0.01% | 4856 |
|
|
2023
Q4 | $121K | Buy |
10,875
+9,875
| +988% | +$110K | ﹤0.01% | 4968 |
|
|
2023
Q3 | $9K | Buy |
+1,000
| New | +$9K | ﹤0.01% | 5963 |
|